Suchergebnisse - "Ansuinelli, Michela"

PubPharm (21)

1

Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML

enthalten in: Blood advances | 2024

von Garcia, J. | Kim, H. | Murdock, H. | +20

2

Digital droplet PCR for T315I BCR::ABL1 KD mutation assessment in adult Ph-positive acute lymphoblastic leukemia with a minimal residual disease increase

enthalten in: Leukemia & lymphoma | 2023

von Cardinali, D. | Beldinanzi, M. | Ansuinelli, M. | +21

3

Cytokine release syndrome in haploidentical stem cell transplant may impact T-cell recovery and relapse

enthalten in: Blood advances | 2023

von Kim, H. | Ansuinelli, M. | Guleria, I. | +11

4

ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings

enthalten in: Leukemia & lymphoma | 2023

von Chiaretti, S. | Taherinasab, A. | Della Starza, I. | +13

5

Circulating cell-free DNA for target quantification in hematologic malignancies : Validation of a protocol to overcome pre-analytical biases

enthalten in: Hematological oncology | 2023

von Soscia, R. | Della Starza, I. | De Novi, L. | +23

6

Circulating cell‐free DNA for target quantification in hematologic malignancies : Validation of a protocol to overcome pre‐analytical biases

enthalten in: Hematological Oncology | 2023

von Soscia, R. | Della Starza, I. | Novi, L. | +23

7

Blast morphology in the diagnostic work-up of Ph-like acute lymphoblastic leukemia

enthalten in: Leukemia & lymphoma | 2022

von Fazio, F. | Cunsolo, G. | Mancini, F. | +12

8

Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia-positive acute lymphoblastic leukaemia

enthalten in: Hematological oncology | 2021

von Ansuinelli, M. | Della Starza, I. | Lauretti, A. | +9

9

New dead/H-box helicase gene (ddx41) mutation in an Italian family with recurrent leukemia

enthalten in: Leukemia & lymphoma | 2021

von Fazio, F. | Quintini, M. | Carmosino, I. | +8

10

Emerging tyrosine kinase inhibitors for the treatment of adult acute lymphoblastic leukemia

enthalten in: Expert opinion on emerging drugs | 2021

von Ansuinelli, M. | Cesini, L. | Chiaretti, S. | +1